South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032
Overview
The South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market is expected to reach a 155.79 USD Million by 2032 and is projected to grow at a CAGR of 13.01% from 2025 to 2032.
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market 2018-2032 USD Million
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 74.74 USD Million
- Projected Market Size (2032): 155.79 USD Million
- CAGR (2025-2032): 13.01%
Key Findings of South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market
- The South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at 74.74 USD Million in 2024.
- The South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market is likely to grow at a CAGR of 13.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 56.93 USD Million
- The fastest growing segment Inhalation of Harmful Substances in Cause Segment grew Fastest with a CAGR of 13.81% during the forecast period from 2024 to 2032.
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- Direct Tender
- Others
- Oral
- Parenteral
- Others
- Tocilizumab
- Extracorporeal Membrane Oxygenation (ECMO)
- Antiviral Medication
- Corticosteroids
- Mechanical Ventilation
- Others
- Severe Pneumonia
- Inhalation of Harmful Substances
- Sepsis
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 74.74 USD Million |
| Market Value in 2032 | 155.79 USD Million |
| CAGR (2025-2032) | 13.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Route of Administration ,Type,Cause |
Regional Insights:
-
Leading Market (2024-2032): South Africa, leading in terms of revenue 74.74 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 74.74 USD Million in 2024.
Segments and Scope
-
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By End User
- Hospitals is the largest segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 53.96 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.21 % in forecast period 2025-2032.
-
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 46.56 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.52 % in forecast period 2025-2032.
-
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 56.93 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.32 % in forecast period 2025-2032.
-
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Type
- Mechanical Ventilation is the largest segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 38.17 USD Million in the year 2024.
- Mechanical Ventilation is the Fastest growing segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.60 % in forecast period 2025-2032.
-
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Cause
- Sepsis is the largest segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 44.40 USD Million in the year 2024.
- Inhalation of Harmful Substances is the Fastest growing segment in South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 13.15 % in forecast period 2025-2032.
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| LivaNova | |||
| Terumo Corporation | |||
| Getinge AB | |||
| Gilead Sciences, Inc. | |||
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- Direct Tender
- Others
- Oral
- Parenteral
- Others
- Tocilizumab
- Extracorporeal Membrane Oxygenation (ECMO)
- Antiviral Medication
- Corticosteroids
- Mechanical Ventilation
- Others
- Severe Pneumonia
- Inhalation of Harmful Substances
- Sepsis
Frequently Asked Questions
South Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.